U.S. Physical Therapy Dividend Details and Recent News: Key Insights Before Ex-Dividend Date Aug 22, 2025
Generated by AI AgentAinvest Dividend Digest
Monday, Aug 18, 2025 7:17 pm ET1min read
USPH--
Aime Summary
U.S. Physical TherapyUSPH-- (USPH) has announced its upcoming dividend details with an ex-dividend date set for Aug 22, 2025. Shareholders can expect a dividend of $0.450 per share on Sep 12, 2025, marking a continuation of their previous payout, which was also $0.450 per share on Jun 13, 2025. Compared to the average of the last 10 dividends, which stands at $0.268 per share, this is a higher-than-usual distribution. This dividend is categorized as a cash dividend.
Recently, U.S. Physical Therapy has been in the spotlight with several significant developments. Earnings for USPHUSPH-- are projected to grow by 9.74% in the coming year, increasing from $2.67 to $2.93 per share. This forecast suggests a positive outlook for the company's financial health and investor returns. Over the past week, USPH has experienced a notable increase in its stock value, closing the last trading session at $86.71, which represents a gain of 17.5% over the past four weeks. This upward trend indicates strong market performance and potential for further appreciation.
As of late, there have been adjustments in earnings expectations. Analysts have revised their Q3 2025 earnings estimate for U.S. Physical Therapy, reducing it from $0.70 to $0.68 per share. The full-year 2025 earnings projection now stands at $2.45 per share, suggesting a more conservative outlook amidst market fluctuations. Despite these changes, USPH delivered earnings and revenue surprises of +14.08% and +3.78%, respectively, for the quarter ended Jun 2025, indicating robust operational performance.
In conclusion, U.S. Physical Therapy is set to distribute a higher-than-average dividend, reflecting its strong financial standing. With the ex-dividend date on Aug 22, 2025, this marks the last opportunity for investors to purchase shares and qualify for the upcoming dividend. Any acquisitions made after this date will not be eligible for the current dividend distribution.
Recently, U.S. Physical Therapy has been in the spotlight with several significant developments. Earnings for USPHUSPH-- are projected to grow by 9.74% in the coming year, increasing from $2.67 to $2.93 per share. This forecast suggests a positive outlook for the company's financial health and investor returns. Over the past week, USPH has experienced a notable increase in its stock value, closing the last trading session at $86.71, which represents a gain of 17.5% over the past four weeks. This upward trend indicates strong market performance and potential for further appreciation.
As of late, there have been adjustments in earnings expectations. Analysts have revised their Q3 2025 earnings estimate for U.S. Physical Therapy, reducing it from $0.70 to $0.68 per share. The full-year 2025 earnings projection now stands at $2.45 per share, suggesting a more conservative outlook amidst market fluctuations. Despite these changes, USPH delivered earnings and revenue surprises of +14.08% and +3.78%, respectively, for the quarter ended Jun 2025, indicating robust operational performance.
In conclusion, U.S. Physical Therapy is set to distribute a higher-than-average dividend, reflecting its strong financial standing. With the ex-dividend date on Aug 22, 2025, this marks the last opportunity for investors to purchase shares and qualify for the upcoming dividend. Any acquisitions made after this date will not be eligible for the current dividend distribution.

Sip from the stream of US stock dividends. Your income play.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet